Filing Flows

Filing Flows › Rockwell Medical (RMTI) › Guidance history

Rockwell Medical (RMTI) guidance history: what it guided and what it reported

Rockwell Medical gave guidance in 3 earnings releases on file since May 7, 2026. Its releases raised guidance once and lowered it 0 times.

Revenue

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$70.0M–$75.0M (May 7, 2026) → reaffirmed $70.0M–$75.0M (Aug 13, 2026)—to be reported—

Gross margin

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY202618.0%–22.0% (May 7, 2026) → reaffirmed 18.0%–22.0% (Aug 13, 2026)—to be reported—

EBITDA

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$1.0M–$2.0M (May 7, 2026)—to be reported—

Adjusted EBITDA

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$1.0M–$2.0M (Aug 13, 2026)—to be reported—

The latest quarter

Rockwell Medical, Q2 2026: revenue $17.8M (+11% year over year), operating margin -6.0%, net loss $1.2M, operating cash flow $2.1M. The chart follows the revenue to costs, profit and cash.

Questions

Does Rockwell Medical beat its guidance?

Rockwell Medical gave guidance in 3 earnings releases on file since May 7, 2026. Its releases raised guidance once and lowered it 0 times.

How often does Rockwell Medical raise guidance?

Its earnings releases raised guidance once and lowered it 0 times since May 7, 2026.

Latest guidance and outlook →

Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.